Abstract
‘Burnout syndrome’ is a progressive mental process whereby individuals are unable to adapt to prolonged and excessive stress at work. The main features of the syndrome are physical and emotional fatigue, depersonalization and frustration with ineffective professional and personal implementation. The first studies carried out in the 1970’s showed that this condition is much more common in the social professions employing teachers, doctors, nurses, social workers and police officers. Currently, the Maslach Burnout Inventory (MBI) is the most important medical research tool for diagnosing level of burnout. Treatment of burnout depend on the severity of the syndrome. In severe forms, in addition to socio-occupational cognitive behavioural therapy, the approach also includes drug treatment with benzodiazepines and antidepressants, particularly the selective serotonin reuptake inhibitors.
The present clinical study evaluated the effectiveness of a nutraceutical product developed in a high-technology formulation containing the metabolic precursors of serotonin and which has been used in previous clinical trials on the treatment of slight to moderate depression. The results in the present study demonstrated the effectiveness of the treatment in subjects with burnout syndrome, especially regarding their mental state, by evaluating the degree of burnout using the MBI scale and self-assessment motivational scores.
Similar content being viewed by others
References
Kaschka WP, Korczak D, Broich K (2011) Burnout—a fashionable diagnosis. Dtsch Arztebl Int 108:781–787
Maslach C, Jackson SE (1981) Maslach Burnout Inventory (“Human Services Sur”). Consulting Psychologists Press, Palo Alto, CA
Maslach C, Schaufeli WB (1993) Historical and conceptual development of burnout. In: Schaufeli WB, Maslach C, Marek T (eds) Professional burnout: recent developments in theory and research. Taylor & Francis, New York, pp 1–16
Maslach C, Jackson SE, Leiter MP (1996) Maslach Burnout Inventory manual, 3rd edn. Consulting Psychologists Press, Palo Alto, CA
Maslach C, Schaufeli WB, Leiter MP (2001) Job burnout. Ann Rev Psychol 52:397–422
Freudenberger HJ (1974) Staff burnout. J Soc Issues 30:159–165
Freudenberger HJ (1982) Counseling and dynamics: treating the endstage person. In: Jones JW (ed) The burnout syndrome. London House Press, Park Ridge, IL
Hobfoll SE, Shirom A (2001) Conservation of resources theory: applications to stress and management in the workplace. In: Golembiewski RT (ed), Handbook of organizational behavior, 2nd ed. Marcel Dekker, New York, pp 57–80
Weber A, Jaekel-Reinhard A (2000) Burnout syndrome: a disease of modern societies? Occup Med 50:512–517
Maslach C, Leiter MP (1997). The truth about burnout. Jossey Bass, San Francisco, CA
Schaufeli WB, Enzmann D (1998) The burnout companion to study and practice: a critical analysis. Taylor & Francis, London
Schaufeli WB, Buunk BP (2004) Burnout: an overview of 25 years of research and theorizing. In: Schabracq MJ, Winnubst JAM, Cooper CL (eds) The handbook of work and health psychology, 2nd edn. Wiley, Chichester, pp 383–425
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edition, text revision
Karasek RA (1979) Job demands, job decision latitude, and mental strain: implications for job redesign. Admin Sci Q 24:285–308.
Siegrist J, Peter R (2000) The effort-reward imbalance model. In: Schnall P, Belkic K, Landsbergis P, Baker D (eds) The workplace and cardiovascular disease. Occup Med 15:83–87
Rossati A, Magro G. (1999) Stress e burnout. Carocci, Rome
Hillert A, Marwitz M (2006) Die Burnout-Epidemie oder brennt die Leistungsgesellschaft aus? CH Beck, Munich
Von Känel R (2008) Das Burnout-Syndrom: eine medizinische Perspektive. The burnout syndrome: a medical perspective. Praxis 97:477–487
Stankov BM, Georgiev T, Gervasoni M, Fauteck JD (2007) Controlled-release formulations containing tryptophan and/or 5-hydroxytryptophan. A controlled clinical trial for mild and moderate depression. Nutrafoods 6:13–18
Stankov BM (2008) Controlled-release formulations containing tryptophan and/or 5-hydroxytryptophan: EP 1 637185 B1.
Gerev V, Pannacci M, Stankov BM, Fauteck JD (2012) Precursori della serotonina a rilascio controllato studio clinico in fumatori depressi in sovrappeso. L’Integratore Nutrizionale 15:23–27
Ahola K, Hakanen J, Perhoniemi R, Mutanen P (2014) Relationship between burnout and depressive symptoms: a study using the person-centred approach. Burnout Res 1:29–37
Bianchi R, Boffy C, Hingray C, Truchot D, Laurent E (2013) Comparative symptomatology of burnout and depression. J Health Psychol 18:782–787
Bianchi R, Schonfeld IS, Laurent E (2015) Burnout–depression overlap: a review. Clin Psychol Rev 36:28–41
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gerev, V., Pannacci, M. & Fauteck, JD. Burnout syndrome: the effects of serotonin precursors. Nutrafoods 14, 189–195 (2015). https://doi.org/10.1007/s13749-015-0048-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13749-015-0048-3